Market Tracker

01/20 5:16pm ET

Exact Sciences Corp (NASDAQ:EXAS)

18.09
Delayed Data
As of Jan 20
 -0.33 / -1.79%
Today’s Change
4.67
Today|||52-Week Range
22.80
+35.40%
Year-to-Date
5 Healthcare Stocks Poised for Maximum Gains in 2017
Jan 17 / MotleyFool.com - Paid Partner Content
Why Exact Sciences Corp. Is Surging 19.3% Today
Jan 09 / MotleyFool.com - Paid Partner Content
Why Exact Sciences' Stock Could Go Much Higher
Jan 13 / MotleyFool.com - Paid Partner Content
Better Buy: Myriad Genetics vs. Exact Sciences
Jan 09 / MotleyFool.com - Paid Partner Content
Why Ariad Pharmaceuticals, VCA, and Exact Sciences Jumped Today
Jan 09 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close18.42
Today’s open18.45
Day’s range17.94 - 18.83
Volume2,397,619
Average volume (3 months)2,631,710
Market cap$2.0B
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-36.80%
Earnings growth (this year)+0.60%
Earnings growth (next 5 years)+22.50%
Revenue growth (last year)+2,093.38%
P/E ratioNM
Price/Sales21.56
Price/Book5.35

Competitors

 Today’s
change
Today’s
% change
RDUSRadius Health Inc+0.03+0.07%
JUNOJuno Therapeutics In...-0.16-0.81%
NKTRNektar Therapeutics-0.23-1.88%
ONCESpark Therapeutics I...+1.23+2.20%
Data as of 4:00pm ET, 01/20/2017

Financials

Next reporting dateFebruary 23, 2017
EPS forecast (this quarter)-$0.41
Annual revenue (last year)$39.4M
Annual profit (last year)-$157.8M
Net profit margin-400.14%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Kevin T. Conroy
Chief Operating Officer, Director &
Senior VP
Maneesh K. Arora
Corporate headquarters
Madison, Wisconsin

Forecasts